Preclinical Characterization of a Novel Monoclonal Antibody NEO-201 for the Treatment of Human Carcinomas
Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2017.01899
Full Text
Open PDFAbstract
Available in full text
Date
January 4, 2018
Authors
Publisher
Frontiers Media SA